A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT) von Mateo, J., Chakravarty, D., Dienstmann, R., Jezdic, S., Gonzalez-Perez, A., Lopez-Bigas, N., Ng, C.K.Y., Bedard, P.L., Tortora, G., Douillard, J.-Y., Van Allen, E.M., Schultz, N., Swanton, C., André, F., Pusztai, L.

Volltext

Neoantigen prediction and computational perspectives towards clinical benefit: recommendations from the ESMO Precision Medicine Working Group von De Mattos-Arruda, L., Vazquez, M., Finotello, F., Lepore, R., Porta, E., Hundal, J., Amengual-Rigo, P., Ng, C.K.Y., Valencia, A., Carrillo, J., Chan, T.A., Guallar, V., McGranahan, N., Blanco, J., Griffith, M.

Volltext

Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle von De Mattos-Arruda, L., Weigelt, B., Cortes, J., Won, H.H., Ng, C.K.Y., Nuciforo, P., Bidard, F.-C., Aura, C., Saura, C., Peg, V., Piscuoglio, S., Oliveira, M., Smolders, Y., Patel, P., Norton, L., Tabernero, J., Berger, M.F., Seoane, J., Reis-Filho, J.S.

Volltext

Genetic profiling using plasma-derived cell-free DNA in therapy-naïve hepatocellular carcinoma patients: a pilot study von Ng, C.K.Y., Di Costanzo, G.G., Tosti, N., Paradiso, V., Coto-Llerena, M., Roscigno, G., Perrina, V., Quintavalle, C., Boldanova, T., Wieland, S., Marino-Marsilia, G., Lanzafame, M., Quagliata, L., Condorelli, G., Matter, M.S., Tortora, R., Heim, M.H., Terracciano, L.M., Piscuoglio, S.

Volltext

Corrections to “Capturing intra-tumor genetic heterogeneity byde novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle” von De Mattos-Arruda, L, Weigelt, B., Cortes, J., Won, H.H., Ng, C.K.Y., Nuciforo, P., Bidard, F.-C., Aura, C., Saura, C., Peg, V., Piscuoglio, S., Oliveira, M., Smolders, Y., Patel, P., Norton, L., Tabernero, J., Berger, M.F., Seoane, J., Reis-Filho, J.S.

Volltext

575 SF3B1 mutations are associated with alternative splicing in ER-positive breast cancer von Maguire, S, Leonidou, A, Wai, P, Marchio, C, Ng, C.K.Y, Weigelt, B, Sapino, A, Vincent-Salomon, A, Reis-Filho, J.S, Natrajan, R

Volltext

Personalised organoid drug treatment and therapy resistance characterization based on novel BRCA2 prostate cancer xenograft of SPOP-like phenotype and microsatellite instability von Karkampouna, S., La Manna, F., De Filippo, M.R., De Menna, M., Zoni, E., Grosjean, J., Klima, I., Garofoli, A., Genitsch, V., Keller, D., Booij, T.H., Stirnimann, C.U., Sboner, A., Ng, C.K.Y., Piscuoglio, S., Spahn, M., Mark, A.R., Thalmann, G.N., Kruithof-De Julio, M.

Volltext

Mechanism of action of a WWTR1(TAZ)-CAMTA1 fusion oncoprotein von Tanas, M R, Ma, S, Jadaan, F O, Ng, C K Y, Weigelt, B, Reis-Filho, J S, Rubin, B P

Volltext

Differential biomass and nutrient accumulation in perennial ryegrass accessions under excess water treatment in field conditions during winter von S. Barth, C.K.Y. Ng, L. Moloney-Finn, J. HumphreyS, S. Alves

Volltext

APOBEC mutagenesis, kataegis, chromothripsis in EGFR-mutant osimertinib-resistant lung adenocarcinomas von Selenica, P., Marra, A., Choudhury, N.J., Gazzo, A., Falcon, C.J., Patel, J., Pei, X., Zhu, Y., Ng, C.K.Y., Curry, M., Heller, G., Zhang, Y.-K., Berger, M.F., Ladanyi, M., Rudin, C.M., Chandarlapaty, S., Lovly, C.M., Reis-Filho, J.S., Yu, H.A.

Volltext

Stroma transcriptomic and proteomic profile of prostate cancer metastasis xenograft models reveals prognostic value of stroma signatures von Karkampouna, S., De Filippo, M.R., Ng, C.K.Y., Klima, I., Zoni, E., Spahn, M., Stein, F., Haberkant, P., Thalmann, G.N., Kruithof-De Julio, M.

Volltext

ESR1 and endocrine therapy resistance: more than just mutations von Piscuoglio, S., Ng, C.K.Y., Weigelt, B., Chandarlapaty, S., Reis-Filho, J.S.

Volltext

Genomic analysis of genetic heterogeneity and evolution in high-grade serous ovarian carcinoma von Cooke, S L, Ng, C K Y, Melnyk, N, Garcia, M J, Hardcastle, T, Temple, J, Langdon, S, Huntsman, D, Brenton, J D

Volltext

Discovery of heterozygous KRT10 alterations in MAUIE cases underlines the importance of regular skin cancer screening in ichthyosis with confetti von Burger, B., Ghosh, A., Ng, C.K.Y., Piscuoglio, S., Spoerri, I., Itin, P.H., Greer, K., Elbaum, D.

Volltext

Patient-derived xenografts and organoids model therapy response in prostate cancer von Karkampouna, S., La Manna, F., Benjak, A., Kiener, M., De Menna, M., Zoni, E., Grosjean, J., Klima, I., Garofoli, A., Bolis, M., Vallerga, A., Theurillat, J., De Filippo, M.R., Genitsch, V., Keller, D., Booij, T.H., Stirnimann, C.U., Eng, K., Sboner, A., Ng, C.K.Y., Piscuoglio, S., Gray, P.C., Rubin, M.A., Thalmann, G.N., Kruithof-De, J.

Volltext

Response to dual HER2 blockade in a patient with HER3-mutant metastatic breast cancer von Bidard, F.-C., Ng, C.K.Y., Cottu, P., Piscuoglio, S., Escalup, L., Sakr, R.A., Reyal, F., Mariani, P., Lim, R., Wang, L., Norton, L., Servois, V., Sigal, B., Vincent-Salomon, A., Weigelt, B., Pierga, J.-Y., Reis-Filho, J.S.

Volltext

Genetic profiling using plasma-derived cell-free DNA in therapy-naïve hepatocellular carcinoma patients: A pilot study von Di Costanzo, G.G., Ng, C.K.Y., Tosti, N., Tortora, R., Paradiso, V., Coto-Llerena, M., Roscigno, G., Perrina, V., Quintavalle, C., Boldanova, T., Wieland, S., Marino-Marsilia, G., Lanzafame, M., Quagliata, L., Condorelli, G., Matter, M.S., Heim, M.H., Guarracino, M., Terracciano, L.M., Piscuoglio, S.

Volltext

evolution of Ca2+ signalling in photosynthetic eukaryotes von Bothwell, J.H.F, Ng, C.K.Y

Volltext

Seeing 'cool' and 'hot'--infrared thermography as a tool for non-invasive, high-throughput screening of Arabidopsis guard cell signalling mutants von Wang, Y, Holroyd, G, Hetherington, A.M, Ng, C.K.Y

Volltext

Orchid pseudobulbs – `false' bulbs with a genuine importance in orchid growth and survival von Ng, Carl Khee Yew, Hew, Choy Sin

Volltext